Shanghai
688098.SSShanghai Shen Lian Biomedical Corporation Price (688098.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
393,983,475
(4.0572)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 193,093,762 | 203,652,967 | 240,922,685 | 267,705,441 | 302,075,997 | 275,137,414 | 253,809,330 | 337,732,400 | 358,429,248 | 328,594,513 | 301,487,059 |
| Net Income | 41,823,385 | 61,140,410 | 75,843,835 | 73,471,839 | 98,677,954 | 87,580,332 | 77,957,157 | 129,514,301 | 110,201,862 | 61,101,436 | 31,518,678 |
| FCF USD | 16,554,018 | 74,407,051 | -11,069,801 | -67,708,935 | -28,837,320 | 42,326,466 | -50,276,499 | -51,832,454 | -98,044,403 | -84,035,734 | -126,106,511 |
| OCF USD | 51,788,300 | 105,978,100 | 30,862,500 | 47,995,287 | 74,605,137 | 121,129,682 | 53,812,891 | 111,730,338 | 90,119,983 | 9,088,188 | 3,525,531 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.34 | 0.26 | 0.00 | 0.00 | 0.01 | 0.03 |
| D/E | 0.00 | 0.00 | 0.14 | 0.00 | 0.05 | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| CA/CL | 1.71 | 1.13 | 1.46 | 1.84 | 2.39 | 3.29 | 5.81 | 7.50 | 6.46 | 7.26 | 7.82 |
| TA/TL | 2.61 | 1.84 | 2.84 | 4.27 | 4.84 | 5.59 | 8.70 | 12.81 | 12.74 | 14.83 | 18.34 |
| Total Debt | 0 | 0 | 45,000,000 | 0 | 27,748,172 | 30,000,000 | 30,021,770 | 652,025 | 513,887 | 445,964 | 1,250,998 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 12.44% | 23.89% | 21.33% | 15.35% | 16.82% | 10.12% | 5.95% | 9.02% | 7.19% | 4.08% | 1.96% |
| ROE | 12.77% | 25.31% | 23.89% | 15.78% | 17.97% | 10.53% | 6.08% | 9.27% | 7.45% | 4.08% | 2.12% |
| ROA | 0.00% | 11.56% | 15.47% | 12.09% | 14.26% | 8.64% | 5.39% | 8.54% | 6.53% | 3.80% | 1.87% |
| NM % | 21.66% | 30.02% | 31.48% | 27.45% | 32.67% | 31.83% | 30.71% | 38.35% | 30.75% | 18.59% | 10.45% |
| FCF / R% | 0.00% | 36.54% | -4.59% | -25.29% | -9.55% | 15.38% | -19.81% | -15.35% | -27.35% | -25.57% | -41.83% |
| FCF / NI% | 39.58% | 121.70% | -14.60% | -92.16% | -29.22% | 48.33% | -64.49% | -40.07% | -93.86% | -137.83% | -422.46% |
| Operating Margin (OM) | 0.00 | 0.75 | 0.28 | 0.46 | 0.66 | 0.97 | 1.22 | 1.16 | 1.26 | 1.43 | 1.54 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.49 | 0.71 | 0.88 | 0.23 | 0.30 | 0.26 | 0.19 | 0.32 | 0.27 | 0.15 | 0.08 |
| SPS | 2.24 | 2.36 | 2.80 | 0.84 | 0.92 | 0.82 | 0.62 | 0.82 | 0.87 | 0.80 | 0.77 |
| OCPS | 0.60 | 1.23 | 0.36 | 0.15 | 0.23 | 0.36 | 0.13 | 0.27 | 0.22 | 0.02 | 0.01 |
| FCPS | 0.19 | 0.86 | -0.13 | -0.21 | -0.09 | 0.13 | -0.12 | -0.13 | -0.24 | -0.20 | -0.32 |
| BVPS | 3.80 | 2.80 | 3.68 | 1.46 | 1.67 | 2.47 | 3.13 | 3.41 | 3.59 | 3.65 | 3.83 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.49 | 0.71 | 0.88 | 0.23 | 0.30 | 0.26 | 0.19 | 0.32 | 0.27 | 0.15 | 0.08 |
| CAGR-SPS | 2.24 | 2.36 | 2.80 | 0.84 | 0.92 | 0.82 | 0.62 | 0.82 | 0.87 | 0.80 | 0.77 |
| CAGR-OCPS | 0.60 | 1.23 | 0.36 | 0.15 | 0.23 | 0.36 | 0.13 | 0.27 | 0.22 | 0.02 | 0.01 |
| CAGR-FCPS | 0.19 | 0.86 | -0.13 | -0.21 | -0.09 | 0.13 | -0.12 | -0.13 | -0.24 | -0.20 | -0.32 |
| CAGR-BVPS | 3.80 | 2.80 | 3.68 | 1.46 | 1.67 | 2.47 | 3.13 | 3.41 | 3.59 | 3.65 | 3.83 |